Founder & CEO, HabitNu
Dr. Rajan has been studying cellular and molecular mechanisms of diabetes at Yale and the University of Chicago for 12 years. During her research career she has closely observed the personal struggles of individuals managing diabetes. Currently every one out of three Americans is at risk for developing type 2 diabetes.
The mission of HabitNu is to build technology platforms for bringing evidence-based disease management programs from laboratories to the public. HabitNu program is a novel approach to a digital therapeutic solution based on peer support and technology to prevent the onset of type 2 diabetes. HabitNu is fully recognized by the Centers for Disease Control (CDC) based on its outcomes.
Dr. Rajan is a subject matter expert and a passionate social entrepreneur. Her goal is to see HabitNu prescribed to everyone who is at risk for developing type 2 diabetes.